Esperion Therapeutics Inc (ESPR) — Cash Flow Reinvestment Rate
Latest as of March 2024:
0.00x
Esperion Therapeutics Inc (ESPR) has a Cash Flow Reinvestment Rate of 0.00x as of March 2024, reinvesting $146.00K (capex $73.00K plus investments $-73.00K) from operating cash flow of $53.83 Million. Explore ESPR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$146.00K
Capex + Investments
Operating Cash Flow
$53.83 Million
USD
Capital Expenditures
$73.00K
USD
Annual Cash Flow Reinvestment Rate for Esperion Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Esperion Therapeutics Inc. For live market cap and broader valuation context, see market cap of Esperion Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow